Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Leqembi
The FDA is poised to make a decision on granting approval to Leqembi – the first drug to show promise in slowing Alzheimer’s disease.
Lecanemab is one of the first experimental drugs for dementia which appears to help in slowing down the progression of cognitive decline.
Subscribe to Updates
Subscribe to receive latest health related news from us
Copyright © Medical Channel Asia 2024.
All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.